Metformin and Ovulation: Its Role in PCOS Fertility
SaveMetformin modestly improves ovulation in PCOS by lowering insulin and androgens, but it is no longer a first-line fertility drug. Guidelines favor letrozole for ovulation induction, and metformin works best as an adjunct, especially with insulin resistance. Live-birth rates are higher with letrozole than with metformin alone.
Last updated: July 2026
Does metformin actually help you ovulate with PCOS?
Metformin modestly raises the chance of ovulation for some women with PCOS, though it works better for certain profiles than others. Metformin is an insulin-sensitizing medication that lowers circulating insulin and androgen levels, which can nudge the ovaries back toward more regular ovulation 1Ref 1American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.Metformin as an insulin-sensitizing agent that lowers insulin and androgen levels, improves menstrual regularity and ovulation (especially with insulin resistance), and commonly causes gastrointestinal side effects in women with PCOS.. PCOS affects roughly 1 in 10 women of reproductive age and ranks among the most common causes of ovulatory infertility 2Ref 2Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.PCOS prevalence of roughly 1 in 10 reproductive-age women, letrozole as preferred first-line agent for ovulation induction with metformin as an adjunct, reduced hyperstimulation risk, use across life stages, and pregnancy continuation considerations.. The effect tends to be strongest in women with measurable insulin resistance or a higher body weight 1Ref 1American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.Metformin as an insulin-sensitizing agent that lowers insulin and androgen levels, improves menstrual regularity and ovulation (especially with insulin resistance), and commonly causes gastrointestinal side effects in women with PCOS.. Recognizing your own PCOS symptoms, such as long or absent cycles, helps signal how inconsistent ovulation may be.
How does metformin compare with letrozole and clomiphene?
Letrozole outperforms both metformin and clomiphene for helping women with PCOS conceive. In the landmark PPCOS II trial, letrozole produced a cumulative live-birth rate of about 27.5% compared with 19.1% for clomiphene 3Ref 3Legro RS, Brzyski RG, Diamond MP, et al. / NICHD Reproductive Medicine Network (2014).Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.The PPCOS II randomized trial showing a cumulative live-birth rate of about 27.5% with letrozole versus 19.1% with clomiphene in women with PCOS.. An earlier trial found metformin alone yielded live births in only about 7.2% of women, versus 22.5% with clomiphene and 26.8% with the two combined 4Ref 4Legro RS, Barnhart HX, Schlaff WD, et al. / Cooperative Multicenter Reproductive Medicine Network (2007).Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.The PPCOS trial reporting live-birth rates of about 7.2% with metformin alone, 22.5% with clomiphene, and 26.8% with the combination, and the gradual time course of any metformin benefit.. According to the 2023 international guideline, letrozole is therefore preferred first-line, with metformin reserved as an adjunct 2Ref 2Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.PCOS prevalence of roughly 1 in 10 reproductive-age women, letrozole as preferred first-line agent for ovulation induction with metformin as an adjunct, reduced hyperstimulation risk, use across life stages, and pregnancy continuation considerations.. Understanding how clomiphene works can clarify why oral options are usually tried before injectable ones.
Who is metformin most likely to help?
Women with clear insulin resistance tend to gain the most ovulatory benefit from metformin. Metformin can improve menstrual regularity and ovulation frequency, and it is often added when metabolic features such as elevated blood sugar accompany PCOS 1Ref 1American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.Metformin as an insulin-sensitizing agent that lowers insulin and androgen levels, improves menstrual regularity and ovulation (especially with insulin resistance), and commonly causes gastrointestinal side effects in women with PCOS.. It may also lower the risk of ovarian hyperstimulation for women going through fertility treatment 2Ref 2Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.PCOS prevalence of roughly 1 in 10 reproductive-age women, letrozole as preferred first-line agent for ovulation induction with metformin as an adjunct, reduced hyperstimulation risk, use across life stages, and pregnancy continuation considerations.. Weight and metabolic health strongly shape results, which is why losing weight with PCOS is frequently discussed alongside medication. In adolescence, clinicians more often use metformin for cycle regularity and metabolic health than for fertility, and ovulation can shift again as women approach the perimenopausal transition 2Ref 2Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.PCOS prevalence of roughly 1 in 10 reproductive-age women, letrozole as preferred first-line agent for ovulation induction with metformin as an adjunct, reduced hyperstimulation risk, use across life stages, and pregnancy continuation considerations..
What are the trade-offs and side effects of metformin?
Gastrointestinal upset is the most common drawback of metformin and the main reason some women stop it. Nausea, diarrhea, and abdominal discomfort affect a substantial minority, though gradual dose increases and extended-release forms often ease them 1Ref 1American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.Metformin as an insulin-sensitizing agent that lowers insulin and androgen levels, improves menstrual regularity and ovulation (especially with insulin resistance), and commonly causes gastrointestinal side effects in women with PCOS.. Metformin is not a quick fix, because any ovulation benefit typically builds over several cycles rather than within a single one 4Ref 4Legro RS, Barnhart HX, Schlaff WD, et al. / Cooperative Multicenter Reproductive Medicine Network (2007).Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.The PPCOS trial reporting live-birth rates of about 7.2% with metformin alone, 22.5% with clomiphene, and 26.8% with the combination, and the gradual time course of any metformin benefit.. It is generally regarded as safe in early pregnancy, but decisions about continuing it belong with a clinician 2Ref 2Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.PCOS prevalence of roughly 1 in 10 reproductive-age women, letrozole as preferred first-line agent for ovulation induction with metformin as an adjunct, reduced hyperstimulation risk, use across life stages, and pregnancy continuation considerations.. Reviewing metformin's side effects can help you set realistic expectations before starting.
When PCOS fertility needs a specialist
A reproductive endocrinologist or gynecologist can tailor ovulation-inducing treatment to your PCOS profile. Metformin is one tool among several, and the best sequence depends on your weight, insulin levels, cycle history, age, and how long you have been trying 2Ref 2Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.PCOS prevalence of roughly 1 in 10 reproductive-age women, letrozole as preferred first-line agent for ovulation induction with metformin as an adjunct, reduced hyperstimulation risk, use across life stages, and pregnancy continuation considerations.. A clinician can also check for other factors, such as thyroid problems, a partner's sperm analysis, or blocked tubes, before assuming PCOS is the only obstacle 5Ref 5Practice Committee of the American Society for Reproductive Medicine (2021).Fertility evaluation of infertile women: a committee opinion.Evaluation of infertility, including assessment of other contributing factors and the standard timing (12 months of trying, or 6 months after age 35) at which evaluation is warranted.. If cycles stay irregular, or a year of trying (or six months after age 35) passes without success, evaluation is reasonable 5Ref 5Practice Committee of the American Society for Reproductive Medicine (2021).Fertility evaluation of infertile women: a committee opinion.Evaluation of infertility, including assessment of other contributing factors and the standard timing (12 months of trying, or 6 months after age 35) at which evaluation is warranted.. Gale can help you prepare questions for that visit.
Common questions
Related
Fertility & conception
Adenomyosis and Fertility: What the Evidence ShowsFertility & conception
Fertility After Depo-Provera: The Realistic TimelineFertility & conception
Insulin Resistance and Ovulation: Beyond PCOS
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When to check in about PCOS and fertility
- —Cycles that stop entirely for more than 3 months when you are not pregnant are a reason to seek clinician review
- —Unusually heavy or prolonged bleeding after months without a period is a reason to seek a gynecology evaluation
- —A year of trying to conceive without success, or six months if you are over 35, is a reason to arrange a fertility evaluation
- —Severe or persistent gastrointestinal side effects from any medication are a reason to seek clinician review
This article is general health education, not medical advice. Whether metformin or another treatment fits your PCOS and fertility goals is a decision to make with a gynecologist or reproductive endocrinologist.
References
- 1.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002656 ✓Metformin as an insulin-sensitizing agent that lowers insulin and androgen levels, improves menstrual regularity and ovulation (especially with insulin resistance), and commonly causes gastrointestinal side effects in women with PCOS.
- 2.Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023). Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/clinem/dgad463 ✓PCOS prevalence of roughly 1 in 10 reproductive-age women, letrozole as preferred first-line agent for ovulation induction with metformin as an adjunct, reduced hyperstimulation risk, use across life stages, and pregnancy continuation considerations.
- 3.Legro RS, Brzyski RG, Diamond MP, et al. / NICHD Reproductive Medicine Network (2014). Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine. doi:10.1056/NEJMoa1313517 ✓The PPCOS II randomized trial showing a cumulative live-birth rate of about 27.5% with letrozole versus 19.1% with clomiphene in women with PCOS.
- 4.Legro RS, Barnhart HX, Schlaff WD, et al. / Cooperative Multicenter Reproductive Medicine Network (2007). Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New England Journal of Medicine. doi:10.1056/NEJMoa063971 ✓The PPCOS trial reporting live-birth rates of about 7.2% with metformin alone, 22.5% with clomiphene, and 26.8% with the combination, and the gradual time course of any metformin benefit.
- 5.Practice Committee of the American Society for Reproductive Medicine (2021). Fertility evaluation of infertile women: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2021.08.038 ✓Evaluation of infertility, including assessment of other contributing factors and the standard timing (12 months of trying, or 6 months after age 35) at which evaluation is warranted.
5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy